期刊文献+

c-SRC基因敲减降低宫颈癌HeLa细胞活性及磷酸化的信号转导与转录激活子-3蛋白表达 被引量:2

c-SRC knockdown decreases phosphorylated STAT3 expression and viability of HeLa cells
原文传递
导出
摘要 本文旨在研究c-SRC蛋白对人宫颈癌HeLa细胞的活性及对磷酸化的信号转导与转录激活子-3(phosphorylated signal transducer and activator of transcription-3,p-STAT3)表达的影响。人宫颈癌HeLa细胞转染c-SRC RNA干涉质粒后,分别用RT-PCR和Westernblot检测细胞内c-SRC mRNA和蛋白的表达;用MTT比色法观察c-SRC敲减后细胞的活性;用流式细胞仪检测细胞周期;同时检测细胞内p-STAT3的表达情况。转染c-SRC RNA干涉质粒后,HeLa细胞内c-SRC mRNA和蛋白的表达显著降低;在转染c-SRC RNA干涉质粒24、48、72及96h后,细胞活性分别下降了23.1%、29.3%、38.6%和45.0%(均P<0.05)。转染c-SRC RNA干涉质粒24、48、72及96h后,HeLa细胞S期细胞数分别下降了5.6%、10.0%、15.2%和19.9%(均P<0.05)。敲减c-SRC后,细胞内p-STAT3的含量也显著下降。与对照组相比,STAT3抑制剂Piceatannol处理细胞24、48、72、96h后,细胞活性分别下降了23.8%、29.7%、37.3%和45.4%(均P<0.05),而Piceatannol预处理细胞后再用重组人c-SRC蛋白处理增加细胞内c-SRC蛋白的含量,细胞活性未见明显增加。以上结果表明,c-SRC敲减后抑制HeLa细胞的活性可能与其抑制STAT3蛋白磷酸化相关。 The present study was to determine the effect of c-SRC on the viability of human cervical cancer HeLa cells and the expression of phosphorylated signal transducer and activator of transcription-3 (p-STAT3) of the cell. Post-transfection of c-SRC RNA interference vector, RT-PCR and Western blot were utilized to observe the contents of c-SRC mRNA and protein, respectively, in HeLa cells. The MTT was used to observe the viability of the cells. Cell cycle was observed by flow cytometry. The content of p-STAT3 in the cells was also investigated after knockdown of c-SRC. Knockdown of c-SRC significantly decreased the contents of c-SRC mRNA and protein in the cells. The viability of the cells decreased by 23.1%, 29.3%, 38.6% and 45.0% (all P 0.05), respectively, after the cells were transfected with c-SRC RNA interference vector for 24, 48, 72, and 96 h. The number of S-phase cells decreased by 5.6%, 10.0%, 15.2% and 19.9% (all P 0.05), respectively, after transfection of c-SRC RNA interference vector for 24, 48, 72, and 96 h. The content of p-STAT3 also decreased when c-SRC was knockdowned. Compared with the control group, after treatment of HeLa cells with STAT3 inhibitor Piceatannol for 24, 48, 72, and 96 h, the cell viability decreased by 23.8%, 29.7%, 37.3% and 45.4% (all P 0.05), respectively, while increase of c-SRC content could not reverse the inhibitory effect. These results suggest that the inhibited viability of HeLa cells caused by knockdown of c-SRC is associated with the decreased content of p-STAT3 protein.
出处 《生理学报》 CAS CSCD 北大核心 2011年第3期198-204,共7页 Acta Physiologica Sinica
基金 supported by the National Natural Science Foundation of China(No.30360032) the Science Foundation of Educational Committee of Jiangxi Province China(No.GJJ09444 GJJ09111) the Scientific Research Foundation for the Scholars of Ph.D.Degree of Nanchang University and Scientific Research Foundation of Nanchang University China
关键词 宫颈癌 C-SRC 信号转导与转录激活子-3 cervical cancer c-SRC signal transducer and activator of transcription-3
  • 相关文献

参考文献2

二级参考文献23

  • 1Coffer P, Lutticken C, van Puijenbreek A, Klop-de Jonge M, Horn F, Kruijer W. Transcriptional regulation of the jun B promoter: analysis of STAT-mediated signal transduction. Oncogene 1995 : 10: 985 - 994.
  • 2Zhong Z, Wen Z, Darnell JE. Stat3: a STAT family member activated by tyrosine phosphoryhtion in response to epidermal growth factor and interleukin-6. Science 1994:264:95-98.
  • 3Abe J, Berk BC. Fyn and JAK2 mediate Ras activation by reactive oxygen species. J Bid Chem 1999; 274:21003 - 21010.
  • 4Carballo M, Conde M, El Bekay R, Martin-Nieto J,Conde J, Becloya FJ, Sobrino F. Oxidative stress triggers STAT3 tyrosine phosphorylation and nuclear translocation in human lymphocytes. J Biol Chem 1999;274:17580 -17586.
  • 5Madamanchi NR, Li S, Patterson C, Runge MS. Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway. Arterioscler Thromb Vase Biol 2001 ;21:321 -326.
  • 6Negoro S, Kunisada K, Fujio Y, Funamoto M, Darville MI, Eizirik DL, Osugi T, Izumi M, Oshima Y, Nakaoka Y, Hirota H, Kishimoto T, Yamauchi-Takihara K. Activation of signal transducer and activator of transcription 3 protects cardiomyocytes from hypoxia/rcoxygenation-induced oxidative stress through the upregulation of manganese superoxide dismutase. Circulation 2001;104:979-981.
  • 7Ogita K, Yoneda Y. Selective potentiation of DNA binding activities of both activator protein 1 and cyclic AMP response dement binding protein through in vivo activa-tion of N-methyl-D-aspartate receptor complex in mouse brain. J Neurochem 1994;63:525-534.
  • 8Shen WH, Zhang CY, Zhang GY. Nuclear factor κB activation is mediated by NMDA and non-NMDA receptor and L-type voltage-gated Ca^2+ channel following severe global ischemia in rat hippocampus. Brain Res 2002;933:23 - 30.
  • 9Debonera F, Aldeguer X, Shen X, Gelman AE, Gao F,Que X, Greenbaum LE, Furth EE, Taub R, Olthoff KM. Activation of interleukin-6/STAT3 and liver regeneration following transplantation. J Surg Res 2001;96:289 - 295.
  • 10Jenab S, Morris PL. Testicular leukemia inhibitory factor(LIF) and LIF receptor mediate phosphorylation of signal transducers and activators of transcription (STAT)-3and STAT-1 and induce c-fos transcription and activator protein-1 activation in rat Sertoli but not germ cells. Endocrinology 1998 ; 139 : 1883 - 1890.

共引文献8

同被引文献29

  • 1Zheng Wei,Xian Jiang,Haiquan Qiao,Bo Zhai,Lianfeng Zhang,Qiang Zhang,Yuanhong Wu,Hongchi Jiang,Xueying Sun.STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells[J]. Cellular Signalling . 2013 (4)
  • 2Siyuan Zhang,Dihua Yu.Targeting Src family kinases in anti-cancer therapies: turning promise into triumph[J]. Trends in Pharmacological Sciences . 2011 (3)
  • 3Daniela Masciocchi,Arianna Gelain,Stefania Villa,Fiorella Meneghetti,Daniela Barlocco.Signal transducer and activator of transcription 3 (STAT3): a promising target for anticancer therapy[J]. Future Med. Chem. . 2011 (5)
  • 4Chel HunChoi,Sang YongSong,HeeseokKang,Yoo‐YoungLee,Chul‐JungKim,Jeong‐WonLee,Tae‐JoongKim,Byoung‐GieKim,Je‐HoLee,Duk‐SooBae.Prognostic significance of p‐STAT3 in patients with bulky cervical carcinoma undergoing neoadjuvant chemotherapy[J]. Journal of Obstetrics and Gynaecology Research . 2010 (2)
  • 5A. Furuhata,A. Kimura,K. Shide,K. Shimoda,M. Murakami,H. Ito,S. Gao,K. Yoshida,Y. Tagawa,K. Hagiwara,A. Takagi,T. Kojima,M. Suzuki,A. Abe,T. Naoe,T. Murate.p27 deregulation by Skp2 overexpression induced by the JAK2V617 mutation[J]. Biochemical and Biophysical Research Communications . 2009 (4)
  • 6R. C. Sobti,Neha Singh,Showket Hussain,Vanita Suri,A. C. Bharti,B. C. Das.Overexpression of STAT3 in HPV-mediated cervical cancer in a North Indian population[J]. Molecular and Cellular Biochemistry . 2009 (1)
  • 7Okamoto Takashi,Inozume Takashi,Mitsui Hiroshi,Kanzaki Mirei,Harada Kazutoshi,Shibagaki Naotaka,Shimada Shinji.Overexpression of GRIM-19 in cancer cells suppresses STAT3-mediated signal transduction and cancer growth. Molecular Cancer . 2010
  • 8Feifei Li,Wanhua Ren,Yanda Zhao.Downregulation of GRIM-19 is associated with hyperactivation of p-STAT3 in hepatocellular carcinoma. Medical Oncology . 2012
  • 9Yu Hua,Pardoll Drew,Jove Richard.STATs in cancer inflammation and immunity: a leading role for STAT3. Nature reviews. Cancer . 2009
  • 10Hsueh Yi-Jen,Chen Hung-Chi,Chu Wing-Keung,Cheng Chien-Chia,Kuo Pei-Ching,Lin Liang-Yu,Ma Hui-Kang,Chen Jan-Kan.STAT3 regulates the proliferation and differentiation of rabbit limbal epithelial cells via a ΔNp63-dependent mechanism. Investigative Ophthalmology . 2011

引证文献2

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部